Epigral Q4 net profit rises 13% to Rs 87 crore

Epigral reported a 13% increase in net profit, reaching ₹87 crore for the March quarter, with revenue up 20% to ₹631 crore. The company's full fiscal year revenue surged 33% to ₹2,565 crore, driven by an 11% rise in overall volumes and a 24% growth in the Derivatives and Specialty business.

Most Recent